References

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

10.1093/annonc/mdn532 · 2009 · External reference

The illness trajectory of elderly cancer patients across cultures: SIOG position paper

10.1093/annonc/mdl178 · 2007 · External reference

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)

10.1016/j.critrevonc.2005.06.003 · 2005 · External reference

Participation of patients 65 years of age or older in cancer clinical trials

10.1200/jco.2003.08.010 · 2003 · External reference

Anemia, cancer, and aging

10.1177/107327480301000606 · 2003 · External reference

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

10.1016/j.ejca.2004.06.019 · 2004 · External reference

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

10.1182/blood-2004-05-1812 · 2004 · External reference

Cancer-related anemia: pathogenesis, prevalence and treatment

10.1159/000083128 · 2005 · External reference

Chemotherapy-induced anemia in adults: incidence and treatment

10.1093/jnci/91.19.1616 · 1999 · External reference

Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the “Health and Anemia” study

10.1371/journal.pone.0001920 · 2008 · External reference

Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy

10.1007/s00432-006-0167-8 · 2007 · External reference

Impact of fatigue on quality of life in oncology patients

10.1016/s0037-1963(00)90063-5 · 2000 · External reference

Fatigue in an older population

10.1111/j.1532-5415.2000.tb04702.x · 2000 · External reference

Anemia and cancer in older persons

2007 · External reference

Mild anemia and the risk of falls in older adults from nursing homes and the community

10.1016/s1525-8610(04)70008-0 · 2004 · External reference

Fatigue and functional dependence in older cancer patients

10.1097/coc.0b013e31816d915f · 2008 · External reference

Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?

10.1046/j.1532-5415.2002.50313.x · 2002 · External reference

New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care

2003 · External reference

The relationship between psychologic distress and cancer-related fatigue

10.1002/cncr.11463 · 2003 · External reference

Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy

10.1093/annonc/mdj038 · 2006 · External reference

Greater risks of chemotherapy toxicity in elderly patients with cancer

2003 · External reference

Association of comorbidity with disability in older women: the Women's Health and Aging Study

10.1016/s0895-4356(98)00124-3 · 1999 · External reference

Symptom Management in the Geriatric Patient

10.1177/107327489800503s17 · 1998 · External reference

Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer

10.1097/jto.0b013e3181c0a128 · 2010 · External reference

Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy

10.1016/s1040-8428(00)00088-3 · 2001 · External reference

Management of cancer in the older person: a practical approach

10.1634/theoncologist.5-3-224 · 2000 · External reference

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

10.1200/jco.2010.29.2201 · 2010 · External reference

The clinical and economic burden of anemia

2010 · External reference

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey

10.1016/j.critrevonc.2009.03.004 · 2009 · External reference

Age, anemia, and fatigue

10.1053/sonc.2002.33534 · 2002 · External reference

Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma

10.1002/cncr.21769 · 2006 · External reference

Anemia in the oncology patient: cognitive function and cancer

10.1097/00002820-200312001-00009 · 2003 · External reference

Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey

10.1007/bf03040915 · 2004 · External reference

The hazards of blood transfusion in historical perspective

10.1182/blood-2008-07-077370 · 2008 · External reference

Duration of red-cell storage and complications after cardiac surgery

10.1056/nejmoa070403 · 2008 · External reference

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature

10.1097/ccm.0b013e3181844677 · 2008 · External reference

Anemia in cancer patients

1998 · External reference

Transfusion and lung injury

10.1016/s1246-7820(01)00111-2 · 2001 · External reference

Relationship between blood transfusion and tumour behaviour

10.1002/bjs.1800781205 · 1991 · External reference

Aging of the immune system: how much can the adaptive immune system adapt?

10.1016/j.immuni.2006.05.001 · 2006 · External reference

Strategies to optimize the use of erythropoietin and iron therapy in oncology patients

10.1111/j.0041-1132.2004.04169.x · 2004 · External reference

Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anemia

10.1159/000158539 · 2008 · External reference

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

10.1200/jco.2004.08.119 · 2004 · External reference

Unresolved reference

External reference

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy

10.1634/theoncologist.12-2-231 · 2007 · External reference

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

10.1182/blood-2007-08-109488 · 2008 · External reference

Ferric carboxymaltosefor the correction of cancer-and chemotherapy-induced anaemiain clinical practice

2011 · External reference

Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy

10.1016/j.ygyno.2009.12.004 · 2010 · External reference

Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia

10.1200/jco.2006.10.4620 · 2008 · External reference

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

10.1200/jco.2010.30.3644 · 2011 · External reference

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha

10.1200/jco.2007.12.2051 · 2008 · External reference

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

10.1038/sj.leu.2404562 · 2007 · External reference

Darbepoetin alfa 300 or 500 mug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia

10.1002/ajh.21779 · 2010 · External reference

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

10.1016/j.ejca.2006.10.014 · 2007 · External reference

September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents

10.1634/theoncologist.13-s3-33 · 2008 · External reference

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients

10.1016/j.critrevonc.2008.07.010 · 2009 · External reference

Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy

10.1016/j.critrevonc.2005.06.001 · 2006 · External reference

Unresolved reference

External reference

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

10.1038/sj.bjc.6605498 · 2010 · External reference

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia

10.1200/jco.2008.19.1130 · 2009 · External reference

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

10.1016/s0140-6736(09)60502-x · 2009 · External reference

Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting

10.1016/s1040-8428(02)00132-4 · 2003 · External reference

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study

10.1016/j.critrevonc.2008.06.010 · 2008 · External reference

Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer

10.1002/cncr.23583 · 2008 · External reference

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial

10.1097/jto.0b013e318031cd62 · 2007 · External reference

Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer

10.3816/clc.2006.n.024 · 2006 · External reference

Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas

10.1093/annonc/mdl953 · 2006 · External reference

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer

10.1093/jjco/hyi059 · 2005 · External reference

Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the “polmone toscano group” (POLTO)

10.1016/j.lungcan.2004.10.008 · 2005 · External reference

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients

2004 · External reference

Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients

2004 · External reference

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

10.1016/s0169-5002(03)00356-8 · 2003 · External reference

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

10.1016/s0169-5002(00)00194-x · 2001 · External reference

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study

10.1016/s0169-5002(99)00098-7 · 2000 · External reference